Regulated information

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

Rapport financier semestriel 2023 (french)

Rapport financier semestriel 2023 (french)

2023 Half-Year Results

Contents
1.H1 2023 Highlights
2.H1 2023 Consolidatedfinancialstatements
3.Strategyand outlook

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

[VIDEO] Présentation des résultats annuels 2022 -French

Présentation analystes & investisseurs - 23 Mars 2023

ANNUAL RESULTS 2022 (slideshow)

01.2022 Highlights
02.2022 Consolidated financial statements
03.Strategy and outlook

2022 HALF YEAR RESULTS Additional information on the Group’s strategy

Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook.

2022 half-year results

This document has been prepared by Vetoquinol for the sole purpose of presenting the half-year results for the fiscal year 2022, on September 15, 2022.

Annual results 2021 (slideshow)

This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022.

[AUDIO] Présentation des résultats 2021

Présentation analystes & investisseurs - 24 mars 2022

[Video] Présentation des résultats semestriels 2022 - french

Présentation analystes & investisseurs - 15 septembre 2022

[VIDEO] Présentation des résultats semestriels 2021 - french

Présentation analystes & investisseurs - 29 juillet 2021

H1 2021 results

H1 2021 results

2021 Half year Financial Report (french)

Half year Financial Report (french version)

[VIDEO ]Présentation des résultats 2020 - french

Présentation analystes & investisseurs - 1er avril 2021

Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.

2020 Half year Financial Report (french)

Half year Financial Report

[VIDEO] Présentation des résultats semestriels 2020 - french

H1 2020 results

H1 2020 Result

[AUDIO] Présentation des résultats 2019

Présentation analystes & investisseurs - 26 mars 2020

2019 annual results

[AUDIO] Présentation des résultats semestriels 2019 - french

Vetoquinol - 25.07.2019 - Enregistrement Audio Conference

2019 Half year Financial Report (french)

Half year Financial Report

H1 2019 RESULTS

H1 2019 results

2018 Annual results

[AUDIO] Présentation des résultats semestriels 2018 - french

Vetoquinol - 26.07.2018 - Enregistrement Audio Conference

H1 2018 results presentation

Slideshow - July 26, 2018

2018 Half year Financial Report

2018 Half year Financial Report

[AUDIO] Présentation des résultats 2017

Présentation analystes & investisseurs - 15 mars 2018

2017 Results

Investors and Analysts - March 15, 2018

2017 Half year Financial Report

2017 Half year Financial Report

H1 results presentation

Slideshow - July 27, 2017

Présentation des résultats 2016 - french

Vétoquinol - 23.03.2017 - 18h15 - Enregistrement Audio Conference

2016 Annual Results

Présentation analystes & investisseurs - 23 mars 2017

Présentation des résultats semestriels 2016 - french

Vétoquinol - 28.07.2016 - 18h15 - Enregistrement Audio Conference

2016 Half year Financial Report

Half year Financial Report

2016 first half results

2016 Half year results

2015 Annual Results

2015 Annual Results

2015 First half Results

2015 Half year results

Half year Financial Report 2015

Half year Financial Report 2015

2014 annual results

Sustained growth, Reference products drive growth in 2014.
<br />
2014 key figures.

Rapport financier semestriel 2014 (french)

2014 First half Results

2014 Half year results

2013 annual results

SFAF meeting March 13, 2014

First half Results

2013 Half year results

Half year financial report 2013

2013 Half year Financial Report

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

2012 ANNUAL RESULTS

SFAF Meeting March 27, 2013

Rapport financier semestriel 2012 (french)

> Rapport d&rsquo;activité semestriel 2012
<br>> Etats financiers consolidés résumés au 30 juin 2012
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2012

First half Results

2012 Half year results

2011 ACTIVITY REPORT

Our business: animals. Our advantage: people.

2011 ANNUAL RESULTS

SFAF meeting April 4, 2012

Rapport financier semestriel 2011 (french)

> Rapport d&rsquo;activité semestriel 2011
<br>> Etats financiers consolidés résumés au 30 juin 2011
<br>> Attestation du responsable du document
<br>> Rapport des commissaires aux comptes sur l&rsquo;information financière semestrielle 2011

2011 Half Year Results

2011 Half year results

2010 Activity Report

P_06 VÉTOQUINOL’S PROUD HISTORY
<br>
P_12 SPOTLIGHT ON INNOVATION
<br>
P_18 AN ONGOING DAILY COMMITMENT
TO VETERINARIANS
<br>
P_24 AN INTERNATIONAL COMPANY
MAINTAINING A LOCAL PRESENCE
IN GLOBAL MARKETS
<br>
P_28 GOVERNANCE AND KEY FIGURES

2010 annual earnings Vétoquinol

Contents :
<br>> Highlights
<br>> 2010 Consolidated
Financial Statements
<br>> Strategy and Outlook
<br>> Questions and Answers

Rapport financier semestriel 2010 (french)

1. Rapport d’activité semestriel 2010
<br>2. États financiers consolidés semestriels résumés au 30 juin 2010
<br>3. Attestation du responsable du document
<br>4. Rapport des Commissaires aux comptes sur l’information financière semestrielle 2010

Vétoquinol: H1 2009 interim earnings

1.‘Hybrid’ growth
<br>2.Stronginterimresults
<br>3.Focus on twostrategicpillars:
<br>- Innovation throughR&D
<br>- Potentialfor externalgrowth
<br>4.Questions and answers

2009 activity report

2009 Annual earnings

2009 Annual earnings

Rapport financier semestriel 2009 (french)

Le chiffre d’affaires de Vétoquinol pour le 1er semestre 2009 s’établit à 119,9 M€, en croissance de 2,7% par rapport au premier semestre de l’exercice précédent.

Vétoquinol: H1 2009 interim earnings

2008 activity report

2008 Annual earnings

Operating highlights
- Key figures
- Revenues
- External growth
- A strategy of product innovation

Rapport semestriel Vétoquinol 2008 (french)

Vétoquinol a réalisé de bons résultats au premier semestre 2008 : le chiffre d’affaires
progresse de 5,0% et le résultat net après impôts de 15,3%.

Vétoquinol: H1 2008 interim earnings

Activity Report 2007

2007 annual earnings Vétoquinol

Etats financiers consolidés du 1er semestre 2007 (french)

Etats financiers consolidés au 31 décembre 2006 (french)